Sahai Anjali
Department of Psychology, Amity University, Noida, Uttar Pradesh, India.
Ann Neurosci. 2025 Sep 8:09727531251369286. doi: 10.1177/09727531251369286.
World Health Organisation (WHO) in 2024 identified that approximately one in 100 children globally has autism spectrum disorder (ASD). ASD is a collection of neurodevelopmental disorders that impact a person's ability to socially interact and communicate, which can typically be noticed in early childhood. While 'autism' as a term was initially used for schizophrenic patients, later psychiatrists Dr. Kanner and paediatrician Dr. Asperger introduced it as a syndrome in children with behavioural differences in social interaction and communication with restrictive and repetitive interests. In today's time, the umbrella term 'ASDs' is used to describe a clinically heterogeneous group of neurodevelopmental disorders (NDDs).
To examine the role of traditional approaches and the potential effectiveness of artificial intelligence (AI) methods in dealing with ASDs for improving the accuracy in its diagnosis and treatment.
The study adopts a narrative review approach to understand the application of AI in ASD. For this purpose, around a hundred research articles were selected from the years 2010-2024. Inclusion and exclusion criteria were identified. The review is organised and grounded on the medical treatment, occupational remedy, vocational remedy, psychology, family remedy and recuperation engineering.
The results show the undisputed role of AI and its ability to identify early indicators of autism, in accordance with the UN Sustainable Development Goal 3 (Good Health and Well-being) and Goal 16 (Peace, Justice and Strong Institutions). Further, healthcare sectors which are using a variety of AI analyses on data sources, genetics, neuroimaging, behavioural patterns and electronic medical records are able to early detect for individualised evaluation of ASD. The significance of timely interventions with the help of machine learning (ML) algorithms demonstrates high accuracy in differentiating ASD from neurotypical development and other developmental disorders.AI-driven therapeutic interventions expand social interactions and communication skills in people with ASD in the form of virtual reality-based training, augmentative communication systems and robot-assisted therapies. Thus, the future of AI in ASD holds promise for improving diagnostic accuracy, implementing telehealth platforms and customising treatment plans, despite obstacles such as data privacy and interpretability.
世界卫生组织(WHO)在2024年确定,全球约每100名儿童中就有1名患有自闭症谱系障碍(ASD)。ASD是一组神经发育障碍,会影响一个人的社交互动和沟通能力,通常在幼儿期就会被注意到。虽然“自闭症”一词最初用于精神分裂症患者,但后来精神病学家坎纳博士和儿科医生阿斯伯格博士将其作为一种综合征引入,用于描述在社交互动和沟通方面存在行为差异且兴趣有限和重复的儿童。在当今时代,“自闭症谱系障碍”这一统称用于描述一组临床异质性的神经发育障碍(NDDs)。
研究传统方法的作用以及人工智能(AI)方法在处理自闭症谱系障碍以提高其诊断和治疗准确性方面的潜在有效性。
本研究采用叙述性综述方法来了解AI在ASD中的应用。为此,从2010年至2024年期间挑选了约100篇研究文章。确定了纳入和排除标准。该综述围绕医学治疗、职业疗法、职业康复、心理学、家庭疗法和康复工程进行组织和阐述。
结果表明,根据联合国可持续发展目标3(良好健康与福祉)和目标16(和平、正义与强大机构),AI在识别自闭症早期指标方面具有无可争议的作用及其能力。此外,对数据源、遗传学、神经影像学、行为模式和电子病历进行各种AI分析的医疗保健部门能够早期检测ASD以进行个体化评估。借助机器学习(ML)算法进行及时干预的重要性在区分ASD与典型神经发育及其他发育障碍方面显示出高准确性。AI驱动的治疗干预以基于虚拟现实的训练、辅助沟通系统和机器人辅助治疗等形式扩展了ASD患者的社交互动和沟通技能。因此,尽管存在数据隐私和可解释性等障碍,但AI在ASD领域的未来有望提高诊断准确性、实施远程医疗平台并定制治疗方案。